|
| Search for Cases |
|
Case Details |
|
Case Code: LAW004
|
| Case Length: 3 Pages |
| Period: 2005-2016 |
| Pub Date: 2016 |
| Teaching Note: Not Available |
| Price: Rs.100 |
| Organization :- |
Industry : Pharmaceutical
|
| Countries : India |
| Themes: -
|
|
|
|
|
IPR: Save Patients or Patents? |
|
|
|
|
| <<Previous Page |
INTRODUCTION |
| |
| In February 2016, the latest US Chamber of Commerce International IP Index placed India at number 37 out of 38 countries, Venezuela scoring the lowest. The listing came at a time when the Indian government was about to launch a new, reframed National Intellectual Property Rights (IPR) policy. The new policy was being framed to be fully compliant with the World Trade Organization’s (WTO) agreement on Trade related aspects of IPRs (TRIPs). The European Union and the US had been pressing India to make changes in section 3(d) of the Indian Patent Act...
|
| |
 |
| or |
 |
| or |
PayPal (2 USD)
|
|
|
| |
|
| |
| |
| |
|
| |
|
|
|
